Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 76420-534

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 76420-534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructurebupren (Chemicalstructure1)

Chemical structure of buprenorphine hydrochloride, showing its molecular arrangement with aromatic rings, functional groups, and hydrochloride notation as part of the compound.*

FDA Label Image

Chemicalstructurenal (Chemicalstructure2)

Chemical structure of buprenorphine hydrochloride showing its molecular framework including the aromatic ring, hydroxyl groups, and nitrogen atoms, along with the designation HCl · 2H2O indicating the dihydrate form.*

FDA Label Image

Containerlabel8mg2mg (Containerlabel8mg2mg)

Label for Buprenorphine and Naloxone Sublingual Tablets 8mg/2mg, packaged in a quantity of 30 tablets. The label shows the NDC number 76420-534-30 and indicates the product is distributed by Accord Healthcare, Inc., relabeled by Enovachem Pharmaceuticals. The label includes dosage form as round biconvex tablets, drug status as schedule CIII, and standard cautionary storage and dispensing information.*

FDA Label Image

Figure1 (Fig1)

An instructional illustration showing a hand placing a sublingual tablet under the tongue inside an open mouth. The image demonstrates the proper placement for sublingual administration of a tablet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.